162 related articles for article (PubMed ID: 24708808)
41. The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.
Trautz B; Pierini V; Wombacher R; Stolp B; Chase AJ; Pizzato M; Fackler OT
J Virol; 2016 Dec; 90(23):10915-10927. PubMed ID: 27681140
[TBL] [Abstract][Full Text] [Related]
42. Nucleolin and the packaging signal, psi, promote the budding of human immunodeficiency virus type-1 (HIV-1).
Ueno T; Tokunaga K; Sawa H; Maeda M; Chiba J; Kojima A; Hasegawa H; Shoya Y; Sata T; Kurata T; Takahashi H
Microbiol Immunol; 2004; 48(2):111-8. PubMed ID: 14978336
[TBL] [Abstract][Full Text] [Related]
43. Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21).
Montefiori DC; Stewart K; Ahearn JM; Zhou J; Zhou J
J Virol; 1993 May; 67(5):2699-706. PubMed ID: 8474169
[TBL] [Abstract][Full Text] [Related]
44. Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1.
Fenouillet E; Gluckman JC; Bahraoui E
J Virol; 1990 Jun; 64(6):2841-8. PubMed ID: 2335819
[TBL] [Abstract][Full Text] [Related]
45. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.
Luo K; Liu B; Xiao Z; Yu Y; Yu X; Gorelick R; Yu XF
J Virol; 2004 Nov; 78(21):11841-52. PubMed ID: 15479826
[TBL] [Abstract][Full Text] [Related]
46. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.
Kaletsky RL; Francica JR; Agrawal-Gamse C; Bates P
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2886-91. PubMed ID: 19179289
[TBL] [Abstract][Full Text] [Related]
47. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
[TBL] [Abstract][Full Text] [Related]
48. Induced Packaging of Cellular MicroRNAs into HIV-1 Virions Can Inhibit Infectivity.
Bogerd HP; Kennedy EM; Whisnant AW; Cullen BR
mBio; 2017 Jan; 8(1):. PubMed ID: 28096489
[TBL] [Abstract][Full Text] [Related]
49. Inter-retroviral fusion mediated by human immunodeficiency virus or murine leukemia virus glycoproteins: independence of cellular membranes and membrane vesicles.
Sparacio S; Pfeiffer T; Holtkotte D; Bosch V
Virology; 2002 Mar; 294(2):305-11. PubMed ID: 12009872
[TBL] [Abstract][Full Text] [Related]
50. 90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1.
Lodermeyer V; Suhr K; Schrott N; Kolbe C; Stürzel CM; Krnavek D; Münch J; Dietz C; Waldmann T; Kirchhoff F; Goffinet C
Retrovirology; 2013 Oct; 10():111. PubMed ID: 24156545
[TBL] [Abstract][Full Text] [Related]
51. Cellular and viral specificities of human immunodeficiency virus type 1 vif protein.
Madani N; Kabat D
J Virol; 2000 Jul; 74(13):5982-7. PubMed ID: 10846079
[TBL] [Abstract][Full Text] [Related]
52. Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells.
Burrer R; Haessig-Einius S; Aubertin AM; Moog C
J Virol; 2003 Nov; 77(21):11385-97. PubMed ID: 14557624
[TBL] [Abstract][Full Text] [Related]
53. Pseudotyping incompatibility between HIV-1 and gibbon ape leukemia virus Env is modulated by Vpu.
Lucas TM; Lyddon TD; Cannon PM; Johnson MC
J Virol; 2010 Mar; 84(6):2666-74. PubMed ID: 20042505
[TBL] [Abstract][Full Text] [Related]
54. Specific selection of host cell glycoproteins during assembly of murine leukaemia virus and vesicular stomatitis virus: presence of Thy-1 glycoprotein and absence of H-2, Pgp-1 and T-200 glycoproteins on the envelopes of these virus particles.
Calafat J; Janssen H; Démant P; Hilgers J; Závada J
J Gen Virol; 1983 Jun; 64 (Pt 6)():1241-53. PubMed ID: 6133909
[TBL] [Abstract][Full Text] [Related]
55. Virus-producing cells determine the host protein profiles of HIV-1 virion cores.
Santos S; Obukhov Y; Nekhai S; Bukrinsky M; Iordanskiy S
Retrovirology; 2012 Aug; 9():65. PubMed ID: 22889230
[TBL] [Abstract][Full Text] [Related]
56. Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1.
Yang X; Kurteva S; Ren X; Lee S; Sodroski J
J Virol; 2005 Oct; 79(19):12132-47. PubMed ID: 16160141
[TBL] [Abstract][Full Text] [Related]
57. Endocytic entry of HIV-1.
Fackler OT; Peterlin BM
Curr Biol; 2000 Aug; 10(16):1005-8. PubMed ID: 10985390
[TBL] [Abstract][Full Text] [Related]
58. CD4/CXCR4 co-expression allows productive HIV-1 infection in canine kidney MDCK cells.
Cervantes-Acosta G; Welman M; Freund F; Cohen EA; Lemay G
Virus Res; 2006 Sep; 120(1-2):138-45. PubMed ID: 16600413
[TBL] [Abstract][Full Text] [Related]
59. MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation.
Yu C; Li S; Zhang X; Khan I; Ahmad I; Zhou Y; Li S; Shi J; Wang Y; Zheng YH
mBio; 2020 Sep; 11(5):. PubMed ID: 32934085
[TBL] [Abstract][Full Text] [Related]
60. Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains.
Brügger B; Krautkrämer E; Tibroni N; Munte CE; Rauch S; Leibrecht I; Glass B; Breuer S; Geyer M; Kräusslich HG; Kalbitzer HR; Wieland FT; Fackler OT
Retrovirology; 2007 Oct; 4():70. PubMed ID: 17908312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
